Ausgabe 1/2013
Inhalt (35 Artikel)
Angiogenesis: a phenomenon which aggravates chronic liver disease progression
Michał Kukla
Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments
Palak J. Trivedi, Sue Cullen
Adenoviral gene therapy in hepatocellular carcinoma: a review
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
Caroline D. M. Witjes, Susanna M. van Aalten, Ewout W. Steyerberg, Gerard J. J. M. Borsboom, Robert A. de Man, Cornelis Verhoef, Jan N. M. IJzermans
Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease
Chan Wah-Kheong, Goh Khean-Lee
The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications
Juan Acevedo, Aníbal Silva, Verónica Prado, Javier Fernández
Paradigms in the management of hepatic hydrothorax: past, present, and future
Sachin Kumar, Shiv Kumar Sarin
Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
Patrick Marcellin, Ferruccio Bonino, Cihan Yurdaydin, Stephanos Hadziyannis, Rami Moucari, Hans-Peter Kapprell, Vivien Rothe, Matei Popescu, Maurizia R. Brunetto
Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay
Wai-Kay Seto, Yasuhito Tanaka, Danny Ka-Ho Wong, Ching-Lung Lai, Noboru Shinkai, John Chi-Hang Yuen, Teresa Tong, James Fung, Ivan Fan-Ngai Hung, Man-Fung Yuen
A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment
Geum-Youn Gwak, Sung June Eo, Su Rin Shin, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22
Okki Cho, Jae Youn Cheong, Ka Jung Jun, Soon Sun Kim, Yong-Joon Chwae, Kyongmin Kim, Sun Park, Sung Won Cho
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, Ivan Fan-Ngai Hung, John Chi-Hang Yuen, Teresa Tong, Ching-Lung Lai, Man-Fung Yuen
Short hairpin RNAs with a 2- or 3-base mismatch inhibit HBV expression and replication in HepG2 cells
Xiaoguang Li, Yuan Hong, Qi Wang, Shunai Liu, Hongshan Wei, Jun Cheng
Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection
Manoj Kumar, Archana Rastogi, Tarandeep Singh, Chhagan Bihari, Ekta Gupta, Praveen Sharma, Hitendra Garg, Ramesh Kumar, Vikram Bhatia, Pankaj Tyagi, Shiv K. Sarin
Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1
Tomoo Miyauchi, Tatsuo Kanda, Fumio Imazeki, Rintaro Mikata, Akinobu Tawada, Makoto Arai, Keiichi Fujiwara, Shingo Nakamoto, Shuang Wu, Takeshi Tanaka, Tatsuo Miyamura, Michio Kimura, Yasuo Hirai, Motohide Takashi, Shigeru Mikami, Nobuyuki Sugiura, Yutaka Natsuki, Ryosaku Azemoto, Noriaki Suzuki, Osamu Yokosuka
Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C
Mina Nakagawa, Naoya Sakamoto, Takako Watanabe, Yuki Nishimura-Sakurai, Izumi Onozuka, Seishin Azuma, Sei Kakinuma, Sayuri Nitta, Kei Kiyohashi, Akiko Kusano-Kitazume, Miyako Murakawa, Kohei Yoshino, Yasuhiro Itsui, Yasuhito Tanaka, Masashi Mizokami, Mamoru Watanabe
Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy
Chun-Hao Chen, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Jeng-Fu Yang, Ming-Yen Hsieh, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
Ching-Sheng Hsu, Shih-Jer Hsu, Hung-Chia Chen, Chen-Hua Liu, Jenher Jeng, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
Chung-Feng Huang, Jee-Fu Huang, Wu-Cheng Chen, Ming-Lun Yeh, Ching-I Huang, Jeng-Fu Yang, Wan-Long Chuang, Chia-Yen Dai, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Lung Yu
Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy
Chia-Yang Hsu, Yun-Hsuan Lee, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Yi-You Chiou, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee
Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma
Zhoujing Zhang, Shengxiang Ge, Xiaomin Wang, Quan Yuan, Qiang Yan, Huiming Ye, Yaojian Che, Yanyan Lin, Jun Zhang, Pingguo Liu
Copy-number variations in hepatoblastoma associate with unique clinical features
Jia-Feng Wu, Chia-Huei Lee, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Jinn-Chyuan Sheu, Daw-Jen Tsuei, Mei-Hwei Chang
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome
Gulanbar Obulhasim, Mahmut Yasen, Kazunori Kajino, Kaoru Mogushi, Shinji Tanaka, Hiroshi Mizushima, Hiroshi Tanaka, Shigeki Arii, Okio Hino
A nationwide population-based study shows increasing incidence of cholangiocarcinoma
Teng-Yu Lee, Jaw-Town Lin, Ken N. Kuo, Ming-Shiang Wu, Hsiu J. Ho, Tzu-Ting Chen, Chun-Ying Wu
Hepatic angiogenesis and fibrosis are common features in morbidly obese patients
Monika Ciupińska-Kajor, Marek Hartleb, Maciej Kajor, Michał Kukla, Mariusz Wyleżoł, Dariusz Lange, Łukasz Liszka
Short- and long-term clinical outcome after balloon-occluded retrograde transvenous obliteration: is pretreatment portal flow direction a predictive factor?
Hidehiro Kamezaki, Hitoshi Maruyama, Taro Shimada, Masanori Takahashi, Hidehiro Okugawa, Osamu Yokosuka
Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial
Shiv Kumar Sarin, Smruti Ranjan Mishra, Praveen Sharma, Barjesh Chander Sharma, Ashish Kumar
The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions
Shih-Cheng Yang, Keng-Liang Wu, Jing-Hung Wang, Chen-Hsiang Lee, Yuan-Hung Kuo, Wei-Chen Tai, Chien-Hung Chen, Shue-Shian Chiou, Sheng-Nan Lu, Tsung-Hui Hu, Chi-Sin Changchien, Seng-Kee Chuah
Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy
Manish Kumar Lunia, Barjesh Chander Sharma, Sanjeev Sachdeva
Spontaneous bacterial empyema in patients with liver cirrhosis in Upper Egypt: prevalence and causative organisms
Hoda A. Makhlouf, Khairy Hammam Morsy, Nahed A. Makhlouf, Eman Nasr Eldin, Mahmoud Khairy
Obesity, type 2 diabetes, age, and female gender: significant risk factors in the development of alcoholic liver cirrhosis
Yoshinori Horie, Yoshiyuki Yamagishi, Hirotoshi Ebinuma, Toshifumi Hibi
Comparative proteomic analysis of human donor tissues during orthotopic liver transplantation: ischemia versus reperfusion
Bin Wu, HongLi Wu, JianNing Chen, XueFeng Hua, Ning Li, MinQiang Lu